Skip to main content

Advertisement

Table 2 Sample TTO Utilities/Categories of Utility

From: 1842676957299765Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities

Utility Mean (SD) (IQR) or n (%)
40% Chance of Erectile Dysfunction** .9156 (.146) (.857 to 1.0)
   No-trade 137 (56.4%)
   .75 to .99 82 (33.7%)
   .50 to .74 19 (7.8%)
   Up to .49 5 (2.1%)
80% Chance of Erectile Dysfunction* .8636 (.187) (.786 to 1.0)
   No-trade 94 (38.7%)
   .75 to .99 108 (44.4%)
   .50 to .74 30 (12.3%)
   Up to .49 11 (4.5%)
10% Chance of Incontinence** .9544 (.120) (.929 to 1.0)
   No-trade 181 (74.5%)
   .75 to .99 52 (21.4%)
   .50 to .74 7 (2.9%)
   Up to .49 3 (1.2%)
30% Chance of Incontinence* .8831 (.186) (.857 to 1.0)
   No-trade 114 (47.7%)
   .75 to .99 92 (38.5%)
   .50 to .74 23 (9.6%)
   Up to .49 10 (4.2%)
40% Chance of Erectile Dysfunction + 10% Chance of Incontinence** .8358 (.196) (.757 to 1.0)
   No-trade 65 (26.6%)
   .75 to .99 133 (54.5%)
   .50 to .74 32 (13.1%)
   Up to .49 14 (5.7%)
  1. TTO = time trade-off
  2. ** Risk associated with Radiation Therapy
  3. *Risk associated with Radical Prostatectomy